| Primary |
| Glaucoma |
60.3% |
| Intraocular Pressure Increased |
9.3% |
| Open Angle Glaucoma |
8.8% |
| Hypertension |
4.0% |
| Ocular Hypertension |
2.3% |
| Intraocular Pressure Test |
2.2% |
| Developmental Glaucoma |
2.0% |
| Diabetes Mellitus |
1.5% |
| Rheumatoid Arthritis |
1.2% |
| Hypothyroidism |
0.9% |
| Keratoconus |
0.9% |
| Normal Tension Glaucoma |
0.9% |
| Blood Pressure Abnormal |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Infection |
0.8% |
| Intraocular Pressure Test Abnormal |
0.8% |
| Anaesthesia |
0.6% |
| Antibiotic Therapy |
0.6% |
| Depression |
0.6% |
| Gastritis |
0.6% |
|
| Product Quality Issue |
12.9% |
| Ocular Hyperaemia |
12.5% |
| Vision Blurred |
11.6% |
| Eye Irritation |
8.9% |
| Visual Acuity Reduced |
8.0% |
| Intraocular Pressure Increased |
7.1% |
| Eye Pain |
4.5% |
| Drug Ineffective |
3.6% |
| Visual Impairment |
3.6% |
| Eye Burns |
3.1% |
| Product Substitution Issue |
3.1% |
| Syncope |
3.1% |
| Glaucoma |
2.7% |
| Death |
2.2% |
| Decreased Appetite |
2.2% |
| Dyspnoea |
2.2% |
| No Adverse Event |
2.2% |
| Pain |
2.2% |
| Pharyngeal Oedema |
2.2% |
| Adverse Event |
1.8% |
|
| Secondary |
| Glaucoma |
49.0% |
| Intraocular Pressure Increased |
12.7% |
| Open Angle Glaucoma |
5.2% |
| Hypertension |
4.3% |
| Drug Use For Unknown Indication |
3.9% |
| Product Used For Unknown Indication |
3.9% |
| Ill-defined Disorder |
2.9% |
| Intraocular Pressure Test |
2.6% |
| Keratoconus |
2.6% |
| Corneal Erosion |
2.2% |
| Normal Tension Glaucoma |
1.6% |
| Intraocular Pressure Test Abnormal |
1.3% |
| Blood Cholesterol Increased |
1.2% |
| Drug Exposure During Pregnancy |
1.2% |
| Eye Infection Toxoplasmal |
1.2% |
| Anaesthesia |
0.9% |
| Diabetes Mellitus |
0.9% |
| Extraocular Muscle Disorder |
0.9% |
| Local Anaesthesia |
0.9% |
| Ocular Discomfort |
0.9% |
|
| Intraocular Pressure Increased |
16.7% |
| Visual Acuity Reduced |
10.1% |
| Thyroid Cancer |
7.2% |
| Ocular Hyperaemia |
5.8% |
| Tinnitus |
5.8% |
| Vision Blurred |
5.1% |
| Dry Eye |
4.3% |
| Syncope |
4.3% |
| Visual Field Defect |
4.3% |
| Eye Disorder |
3.6% |
| Eye Irritation |
3.6% |
| Eye Pain |
3.6% |
| Intraocular Pressure Test Abnormal |
3.6% |
| Product Quality Issue |
3.6% |
| Visual Impairment |
3.6% |
| Bradycardia |
2.9% |
| Decreased Appetite |
2.9% |
| Erythema |
2.9% |
| Glaucoma |
2.9% |
| Reaction To Drug Excipients |
2.9% |
|
| Concomitant |
| Glaucoma |
24.1% |
| Product Used For Unknown Indication |
23.5% |
| Drug Use For Unknown Indication |
14.3% |
| Hypertension |
8.6% |
| Pain |
3.0% |
| Diabetes Mellitus |
3.0% |
| Rheumatoid Arthritis |
2.6% |
| Osteoporosis |
2.3% |
| Prophylaxis |
2.3% |
| Constipation |
2.0% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Blood Cholesterol Increased |
1.8% |
| Atrial Fibrillation |
1.7% |
| Type 2 Diabetes Mellitus |
1.5% |
| Intraocular Pressure Increased |
1.4% |
| Non-small Cell Lung Cancer |
1.4% |
| Infection Prophylaxis |
1.3% |
| Prostate Cancer |
1.3% |
| Dry Eye |
1.2% |
| Depression |
1.1% |
|
| Intraocular Pressure Increased |
11.7% |
| Visual Acuity Reduced |
11.4% |
| Vomiting |
9.3% |
| Weight Decreased |
9.1% |
| Vision Blurred |
6.2% |
| Drug Ineffective |
4.9% |
| Cataract |
4.4% |
| Death |
4.4% |
| Visual Impairment |
4.4% |
| Urinary Tract Infection |
3.9% |
| Glaucoma |
3.4% |
| Ocular Hyperaemia |
3.4% |
| Hypertension |
3.1% |
| Loss Of Consciousness |
3.1% |
| Pneumonia |
3.1% |
| Weight Increased |
3.1% |
| Cerebrovascular Accident |
2.8% |
| Myocardial Infarction |
2.8% |
| Pain |
2.8% |
| Myalgia |
2.6% |
|
| Interacting |
| Glaucoma |
42.1% |
| Atrial Fibrillation |
15.8% |
| Arrhythmia |
10.5% |
| Hyperthyroidism |
10.5% |
| Atrial Flutter |
5.3% |
| Erectile Dysfunction |
5.3% |
| Hypertension |
5.3% |
| Nerve Injury |
5.3% |
|
| Cardiogenic Shock |
25.0% |
| Drug Interaction |
12.5% |
| Erectile Dysfunction |
12.5% |
| Hypersensitivity |
12.5% |
| Infection |
12.5% |
| Pain |
12.5% |
| Sleep Disorder |
12.5% |
|
